News
MCK
518.16
-1.48%
-7.76
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), McKesson (MCK)
TipRanks · 2d ago
McKesson Is Maintained at Overweight by Morgan Stanley
Dow Jones · 3d ago
Weekly Report: what happened at MCK last week (0408-0412)?
Weekly Report · 3d ago
AbbVie keeps Humira market share near 100% despite biosimilars: report
Healthcare AbbVie keeps Humira market share near 100% despite biosimilars: report. Humira is the world's bestselling drug for the 10th year in a row. Amgen launched the first biosimilar version of the arthritis drug in the U.S. Last year.
Seeking Alpha · 5d ago
Global Stock leaders for 2030 in Health Tech - UBS
UBS highlights companies in the greentech, enabling tech, fintech, and healthtech sectors. The need for waste reduction and efficiency could be catalysts for rising healthcare spending. When it comes to healthtech, spending as a percentage of global GDP is almost 11%. UBS lists these global stocks as leaders in the healthtech space.
Seeking Alpha · 04/10 17:49
Stocks Retreat as Bond Yields Surge on US Price Pressures
US March CPI came in hotter than expected for a third straight month. The S&P 500 index closes down -0.95%, the Dow Jones industrials down -1.09%. A surge in T-note yields and a jump in inflation expectations hurt stocks Wednesday. The stronger-than-expected Mar CPI report also reduced Fed rate cut expectations.
Barchart · 04/10 15:35
McKesson Price Target Raised to $570.00/Share From $510.00 by Argus Research
Dow Jones · 04/10 15:33
McKesson Is Maintained at Buy by Argus Research
Dow Jones · 04/10 15:33
Argus Research Maintains Buy on McKesson, Raises Price Target to $570
Benzinga · 04/10 15:23
Stocks Tumble as Sticky US CPI Curbs the Outlook for Fed Rate Cuts
S&P 500 falls to a 3-week low and the Dow Jones Industrials drops to a 1-1/2 month low. Stronger-than-expected US Mar CPI report hammered T-note prices and reduced Fed rate cut expectations. Q1 corporate earnings season begins with JPMorgan Chase on Friday. European government bond yields today are moving higher.
Barchart · 04/10 10:23
Stocks Sink as US CPI Tops Forecasts
S&P 500 falls to a 3-week low and Dow Jones Industrials drop to a 1-1/2 month low. Stronger-than-expected US Mar CPI comes in hotter than expected for a third straight month. The 10-year T-note yields jump to a 5-month high after the report. Fed rate cut expectations are also undercutting stocks. Q1 corporate earnings season begins this Friday.
Barchart · 04/10 09:33
Weekly Report: what happened at MCK last week (0401-0405)?
Weekly Report · 04/08 09:08
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
NASDAQ · 04/05 13:15
MCKESSON CORP <MCK.N>: JEFFERIES RAISES TARGET PRICE TO $620 FROM $530
Reuters · 04/05 11:38
McKesson Corporation (NYSE:MCK) is a favorite amongst institutional investors who own 88%
The top 23 shareholders of McKesson Corporation (NYSE:MCK) own 50% of the company. Institutions own more than half of the shares in McKesson. The company has a large number of institutions owning shares. This suggests the company has strong institutional ownership. McKesson is owned by a large group of shareholders, but the company is growing. It's worth looking at the company's ownership of shares to see if insiders are buying or selling.
Simply Wall St · 04/05 11:15
MCKESSON CORP <MCK.N>: BAIRD RAISES TARGET PRICE TO $603 FROM $584
Reuters · 04/05 05:16
Markets broaden out as all-time highs are seen across ALL, CAT, DELL, RJF, and more
On the Move Markets broaden out as all-time highs are seen across ALL, CAT, DELL, RJF, and more on Thursday. 113 names have hit all- time trading highs on the day. The broadening of the market was also seen across multiple sectors and industries.
Seeking Alpha · 04/04 16:49
BUZZ-'Generally steady' results likely from drug distributors in Q1 2024, Leerink Partners says
Brokerage Leerink Partners says generally steady quarterly results likely from drug distributors in Q1 2024. Raises PT on Cardinal Health's CAH.N and raises PT on Cencora COR to $275 and $600. Sees comfort in prescription trends to support generally steady results for U.S. Drug distributors.
Reuters · 04/03 17:53
MCKESSON CORP <MCK.N>: LEERINK PARTNERS RAISES TARGET PRICE TO $606 FROM $600
Reuters · 04/03 10:38
Top Stock Reports for Apple, NVIDIA & Eli Lilly
NASDAQ · 04/01 18:38
More
Webull provides a variety of real-time MCK stock news. You can receive the latest news about McKesson through multiple platforms. This information may help you make smarter investment decisions.
About MCK
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps solve medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Its Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies. Its International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada.